Striving for new therapies that make patients' lives better
We have an extensive pipeline of investigational product candidates that are progressing through all stages of human clinical trials. Our product candidates address many serious medical conditions including cancer, eye diseases, inflammatory diseases, pain, cardiovascular diseases, and allergic conditions.
Peter Powchik, M.D.
Senior Vice President, Clinical Development
"We have the enviable ability to add several additional fully human antibodies to the clinical pipeline each year due to the productivity of our discovery and development platforms." VelociGene® Technology
Regeneron scientists have developed novel methods for assigning functions to genes and creating preclinical disease models.
More On Our Technology Platform
Clinical Trials
Regeneron has investigational product candidates progressing through all stages of human clinical trials.
See if there are clinical trials that might be right for you
|
||||||||||||||||
|
||||||||||||||||
|
This section discusses pipeline drug candidates currently undergoing clinical testing in a variety of diseases. The safety and efficacy of these drug candidates have not been evaluated by any regulatory authorities for the indications described in this section.
